Primary Record
EGFR-IN-7
- In stock
- 1,892 g
- Purity
- 98.2 %
- CAS
- 2267329-76-8
Compound Identifiers & Properties
- CAS
- 2267329-76-8
- PubChem CID
- 138911391
- SMILES
- CC1=CC(=C(C=C1N2CCC(CC2)N3CCN(CC3)C)OC)NC4=NC=C(C(=N4)NC5=C(C6=NC=CN=C6C=C5)P(=O)(C)C)Br
- Canonical SMILES
- COc1cc(N2CCC(N3CCN(C)CC3)CC2)c(C)cc1Nc1ncc(Br)c(Nc2ccc3nccnc3c2P(C)(C)=O)n1
Names & Synonyms
- EGFR-IN-7
- 2267329-76-8
- TQB3804
- tqb-3804
- RefChem:1100200
- C32H41BrN9O2P
- orb1309717
- CHEMBL5169450
- SCHEMBL22025688
- SCHEMBL30381642
- Egfr-IN-7(TQB3804 )
- GTPL12983
- TBQ3804
- BDBM561454
- Egfr-IN-7(TQB3804 )?
- GLXC-22798
- BCP34208
- EGFR-IN-7 (TQB3804)
- EX-A4322
- SQD32976
- TQB 3804
- TQB3804 (EGFR-IN-7)
- US11390625, Compound 34
- US11390625, Example 34
- s6698
- AKOS040733074
- AT31337
- compound 50 [PMID: 34323489]
- Example 34 [WO2019015655]
- DA-73040
- EGFR Mutant-selective Inhibitor TQB3804
- HY-128862
- CS-0101441
- (6-((5-Bromo-2-((2-methoxy-5-methyl-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)pyrimidin-4-yl)amino)quinoxalin-5-yl)dimethylphosphine oxide
- 5-bromo-N4-[5-(dimethylphosphinyl)-6-quinoxalinyl]-N2-[2-methoxy-5-methyl-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-2,4-pyrimidinediamine
- A935219
- Epidermal Growth Factor Receptor Inhibitor TQB3804
- 5-bromo-4-N-(5-dimethylphosphorylquinoxalin-6-yl)-2-N-[2-methoxy-5-methyl-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]pyrimidine-2,4-diamine
- 5-bromo-4-N-(5-dimethylphosphorylquinoxalin-6-yl)-2-N-(2-methoxy-5-methyl-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)pyrimidine-2,4-diamine
- 5-bromo-N4-(5-dimethylphosphorylquinoxalin-6-yl)-N2-[2-methoxy-5-methyl-4-[4-(4-methylpiperazin-1-yl)-1-piperidyl]phenyl]pyrimidine-2,4-diamine
- 5-bromo-N4-[5-(dimethylphosphoryl)quinoxalin-6-yl]-N2-{2-methoxy-5-methyl-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}pyrimidine-2,4-diamine
- N/A